Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Clin Cancer Res. 2011 Sep 9;17(21):6858–6866. doi: 10.1158/1078-0432.CCR-11-0995

Figure 2.

Figure 2

Figure 2

a. Progression-free survival for all eligible patients on ANBL0321 by stratum (n=62). The numbers at risk at the start of years 1–4 are given along the curves.

b. Overall survival for all eligible patients on ANBL0321 by stratum (n=62). The numbers at risk at the start of years 1–4 are given along the curves.